PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9002984-5 1997 The beta 3-, beta L-, and beta 2-adrenoceptor agonists BRL 37344, dobutamine, and terbutaline inhibited ob gene expression in mouse brown adipocytes differentiated in culture with EC50 values of 0.3, 1.0, and 85 nM, respectively. Terbutaline 82-93 adrenergic receptor, beta 2 Mus musculus 4-45 2894339-6 1987 Thus, phentolamine (2.6 mumol/kg), impaired the glucagon secretory response to the beta 2-adrenoceptor agonist terbutaline by 51% (P less than 0.01), and to the cholinergic agonist carbachol by 44% (P less than 0.02). Terbutaline 111-122 adrenergic receptor, beta 2 Mus musculus 83-102 8096820-7 1993 A marked insulin release following the injection of a maximal dose of the beta 2-adrenoceptor agonist, terbutaline, was accompanied by an increase (30-50%) in islet monoamine oxidase activity. Terbutaline 103-114 adrenergic receptor, beta 2 Mus musculus 74-93 3047591-7 1988 In contrast, the insulin response to the cholinergic agonist carbachol (0.16 mumol/kg) or the beta 2-adrenoceptor agonist terbutaline (3.6 mumol/kg) was not affected by PHI. Terbutaline 122-133 adrenergic receptor, beta 2 Mus musculus 94-113 2464535-11 1988 The study also showed that galanin potently inhibits insulin secretion stimulated by the octapeptide of cholecystokin and by the beta 2-adrenoceptor agonist terbutaline, and that pancreastatin inhibits terbutaline-induced insulin secretion. Terbutaline 157-168 adrenergic receptor, beta 2 Mus musculus 129-148 8387193-10 1993 At 2 min after injection of different doses of glucose mixed with a maximal dose of terbutaline, the insulin secretory response was either increased (submaximal glucose dose) or unaffected (maximal dose of glucose) by the beta 2-adrenoceptor stimulator. Terbutaline 84-95 adrenergic receptor, beta 2 Mus musculus 222-241 34739146-0 2021 Mechanical loading alleviated the inhibition of beta2-adrenergic receptor agonist terbutaline on bone regeneration. Terbutaline 82-93 adrenergic receptor, beta 2 Mus musculus 48-73 34739146-3 2021 Therefore, we hypothesized that precisely controlling the mechanical environment can contribute to the alleviation of the negative effects of chronic treatment with the common asthma drug terbutaline, which is a beta2-adrenergic receptor agonist that facilitates bone homeostasis and defect repair through its anabolic effect on osteogenic cells. Terbutaline 188-199 adrenergic receptor, beta 2 Mus musculus 212-237 2866660-10 1985 Glucose (+55%) and the cholinergic agonist carbachol (+140%) displayed a potentiated insulin secretory response after phentolamine pretreatment, whereas the beta 2-adrenoceptor agonist terbutaline (-45%) had a blunted, though not abolished, insulin response. Terbutaline 185-196 adrenergic receptor, beta 2 Mus musculus 157-176 3329090-6 1987 In contrast, glucagon secretion stimulated by the beta 2-adrenoceptor agonist terbutaline was markedly inhibited by NPY already at the lower dose level (P less than 0.01) and potentiated by CGRP (P less than 0.01). Terbutaline 78-89 adrenergic receptor, beta 2 Mus musculus 50-69 6134629-2 1983 The non-selective beta-adrenoceptor agonist isopropylnoradrenaline and the selective beta 2-adrenoceptor agonist terbutaline both, and with the same efficacy, enhanced radioiodine release, whereas the selective beta 1-adrenoceptor agonist prenalterol had no such effect. Terbutaline 113-124 adrenergic receptor, beta 2 Mus musculus 85-104 6090153-5 1984 Naloxone moderately potentiated the insulin secretory responses to glucose and the beta 2-adrenoceptor agonist terbutaline. Terbutaline 111-122 adrenergic receptor, beta 2 Mus musculus 83-102 6134629-3 1983 The non-selective beta-adrenoceptor antagonist L-propranolol and the selective beta 2-adrenoceptor antagonist ICI 118,551 both abolished the radioiodine release induced by isopropylnoradrenaline or by terbutaline. Terbutaline 201-212 adrenergic receptor, beta 2 Mus musculus 79-98 7025578-3 1981 Contrary to these findings, the insulin response to the beta 2-adrenoceptor agonist terbutaline was potentiated, by about 75%. Terbutaline 84-95 adrenergic receptor, beta 2 Mus musculus 56-75 32592771-0 2020 The beta2-adrenoceptor agonist bronchodilators terbutaline and orciprenaline are also weak alpha1-adrenoceptor antagonists. Terbutaline 47-58 adrenergic receptor, beta 2 Mus musculus 4-22 6264383-8 1981 The insulin secretory response to the beta 2-adrenoceptor stimulator, terbutaline, was increased after chemical sympathectomy, unaffected by adrenalectomy, and decreased after chemical sympathectomy plus adrenalectomy. Terbutaline 70-81 adrenergic receptor, beta 2 Mus musculus 38-57 34369-1 1978 Terbutaline sulfate, a new synthetic beta2-adrenoceptor agonist, was found to produce a dose-related increase in 59Fe-incorporation into newly formed red blood cells of exhypoxic polycythemic mice. Terbutaline 0-19 adrenergic receptor, beta 2 Mus musculus 37-55 32592771-1 2020 Recently, the beta2-adrenoceptor agonist terbutaline was shown to have alpha1-adrenolytic activity in mouse isolated pulmonary arteries in vitro and to lower pulmonary artery pressure in anaesthetised mice. Terbutaline 41-52 adrenergic receptor, beta 2 Mus musculus 14-32 18814973-11 2008 Importantly, administration of the beta-2 adrenergic receptor agonist terbutaline also caused social withdrawal while administration of the beta-2 adrenergic receptor antagonist butoxamine blocked NE-induced social withdrawal. Terbutaline 70-81 adrenergic receptor, beta 2 Mus musculus 35-61 32429330-7 2020 Globally, selective beta2 adrenergic receptor agonist terbutaline decreased the innate response of monocytes from lean and obese sedentary animals, whereas exercise stimulated it. Terbutaline 54-65 adrenergic receptor, beta 2 Mus musculus 20-45 27840124-7 2016 Furthermore, intrathecal treatment with a selective beta2-adrenergic receptor agonist, terbutaline, but not a selective beta1-adrenergic receptor agonist, dobutamine, also significantly ameliorated neuropathic pain. Terbutaline 87-98 adrenergic receptor, beta 2 Mus musculus 52-77 25161169-8 2014 The potency and the maximal effect of the beta2-adrenoceptor agonist terbutaline were lower in Pnmt-KO than in wild-type (WT) mice. Terbutaline 69-80 adrenergic receptor, beta 2 Mus musculus 42-60 24088990-0 2013 Aquaporin 1 and 5 expression evoked by the beta2 adrenoreceptor agonist terbutaline and lipopolysaccharide in mice and in the human monocytic cell line THP-1 is differentially regulated. Terbutaline 72-83 adrenergic receptor, beta 2 Mus musculus 43-63 21870426-8 2011 Cell-surface beta2AR of CD4+ T lymphocytes decreased (15.27%) after terbutaline treatment, but recovered after beta-arrestin 2 RNAi down-modulation. Terbutaline 68-79 adrenergic receptor, beta 2 Mus musculus 13-20 29295855-4 2018 We found that the beta2 adrenoceptor (AR) agonists terbutaline (TER) and salbutamol induced a dose-dependent vasorelaxation in large pulmonary arteries but not aortas of mouse. Terbutaline 51-62 adrenergic receptor, beta 2 Mus musculus 18-36 29295855-10 2018 Thus, beta2 AR agonists display alpha-adrenolytic activity in pulmonary arteries ex vivo and in vivo, and may provide a novel option to reduce pulmonary arterial pressure in pulmonary hypertension.-Neumann, V., Knies, R., Seidinger, A., Simon, A., Lorenz, K., Matthey, M., Breuer, J., Wenzel, D. The beta2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via alpha adrenoceptor antagonism. Terbutaline 314-325 adrenergic receptor, beta 2 Mus musculus 6-14 29485127-12 2018 Moreover, the beta2-AR agonist terbutaline (Terb) inhibited CIA-induced CD4+ T cell proliferation and shift towards Th17 phenotype, and the protein kinase A (PKA) inhibitor H-89 abolished the agonist effect. Terbutaline 31-42 adrenergic receptor, beta 2 Mus musculus 14-22 29485127-12 2018 Moreover, the beta2-AR agonist terbutaline (Terb) inhibited CIA-induced CD4+ T cell proliferation and shift towards Th17 phenotype, and the protein kinase A (PKA) inhibitor H-89 abolished the agonist effect. Terbutaline 44-48 adrenergic receptor, beta 2 Mus musculus 14-22 30460079-3 2017 injections with dobutamine (beta1-adrenergic receptor agonist) or terbutaline (beta2-adrenergic receptor agonist) caused an elevation of the blood glucose level, whereas metoprolol (beta1-adrenergic receptor antagonist) or butoxamine (beta2-adrenergic receptor antagonist) did not. Terbutaline 66-77 adrenergic receptor, beta 2 Mus musculus 79-104 30460079-3 2017 injections with dobutamine (beta1-adrenergic receptor agonist) or terbutaline (beta2-adrenergic receptor agonist) caused an elevation of the blood glucose level, whereas metoprolol (beta1-adrenergic receptor antagonist) or butoxamine (beta2-adrenergic receptor antagonist) did not. Terbutaline 66-77 adrenergic receptor, beta 2 Mus musculus 235-260 23978467-10 2013 This indirect anti-TNFalpha action was observed with the tricyclic antidepressant nortriptyline, the selective serotonin and noradrenaline reuptake inhibitor venlafaxine and the beta2-AR agonist terbutaline. Terbutaline 195-206 adrenergic receptor, beta 2 Mus musculus 178-186 21352833-8 2011 Our data show that a chronic treatment with the beta(2)-AR agonist terbutaline at low antiallodynic dose does not affect cardiovascular parameters, whereas the mixed beta(1)/beta(2)-AR agonist isoproterenol induces cardiac hypertrophy. Terbutaline 67-78 adrenergic receptor, beta 2 Mus musculus 48-58 14565945-7 2004 The response to terbutaline was significantly decreased in type II cells from beta(2)-adrenergic receptor null mice. Terbutaline 16-27 adrenergic receptor, beta 2 Mus musculus 78-105 9366411-2 1997 In the present study, we proposed that the level of beta 2AR expression on anti-CD3 mAb-activated CD4+ effector Th cells may differ from the level on resting cells, and that a change in receptor expression may alter the functional responsiveness of these cells to either the beta 2AR-selective ligand terbutaline or the sympathetic neurotransmitter norepinephrine. Terbutaline 301-312 adrenergic receptor, beta 2 Mus musculus 52-60 11120594-1 2000 We recently showed that clones of Th1 cells, but not Th2 cells, expressed a functional beta-2-adrenergic receptor (beta2AR) and that either norepinephrine or the beta2AR agonist terbutaline stimulated this receptor to modulate the level of Th1 cytokines produced. Terbutaline 178-189 adrenergic receptor, beta 2 Mus musculus 87-113 11120594-1 2000 We recently showed that clones of Th1 cells, but not Th2 cells, expressed a functional beta-2-adrenergic receptor (beta2AR) and that either norepinephrine or the beta2AR agonist terbutaline stimulated this receptor to modulate the level of Th1 cytokines produced. Terbutaline 178-189 adrenergic receptor, beta 2 Mus musculus 115-122 11120594-1 2000 We recently showed that clones of Th1 cells, but not Th2 cells, expressed a functional beta-2-adrenergic receptor (beta2AR) and that either norepinephrine or the beta2AR agonist terbutaline stimulated this receptor to modulate the level of Th1 cytokines produced. Terbutaline 178-189 adrenergic receptor, beta 2 Mus musculus 162-169 11120594-2 2000 In the present study, we show that norepinephrine and terbutaline stimulate the beta2AR to decrease the level of IL-2 produced by freshly isolated murine splenic naive CD4+ T cells from either Balb/C or DO11.10 transgenic mice and activated polyclonally with anti-CD3 and anti-CD28 mAbs. Terbutaline 54-65 adrenergic receptor, beta 2 Mus musculus 80-87 10878340-2 2000 Trinitrophenyl-specific B cells enriched from unimmunized mouse spleens were pre-exposed to Ag and/or the beta 2AR ligand terbutaline for 24 h before being activated by either a beta 2AR-negative Th2 cell clone or CD40 ligand/Sf9 cells and IL-4 in the presence or absence of an anti-CD86 Ab. Terbutaline 122-133 adrenergic receptor, beta 2 Mus musculus 106-114 9126981-4 1997 Clones of murine Th1/Th2 cells were exposed to the beta2AR agonist terbutaline before activation by Ag-presenting B cells. Terbutaline 67-78 adrenergic receptor, beta 2 Mus musculus 51-58